Bone health

Bisphosphonates ‘holiday’ gets the clinical nod

Patients using bisphosphonates to treat osteoporosis could benefit from a ‘drug holiday’ after three to five years of treatment, new US guidelines recommend. The new report by a task force of the American Society for Bone and Mineral Research has been welcomed by Professor Peter Ebeling, head of the department of Medicine at the School ...

Already a member?

Login to keep reading.

© 2021 the limbic